susceptible to experimental infection, and exposure to the virus either results in the experimental disease, or, provoking no response, leaves the animal susceptible to subsequent infection. So far as our knowledge goes, immunity develops in the monkey only through an attack of the experimental disease or by vaccination.
In a preliminary communication t we reported briefly on apparent successful alteration in susceptibility of rhesus monkeys to intranasal instillations of potent virus, and the subsequent development in most of the resistant animals of what appears to be an active immunity, as indicated by both the neutralization and intracerebral tests. We had, it appeared, succeeded in vaccinating the animals by the nasal route, to the best of our knowledge a hitherto unrecorded phenomenon. In the present paper we wish to present in detail the procedures and further results of the experiments which we believe are significant from epidemiologic and theoretical points of view, and which perhaps may have some practical bearing.
Protective Action of Pituitrin S and Adrephine (5 Days Preliminary
Treatment) Experiment/.--Each of 7 animals received pituitrin S and adrephine as described above, every 12 hours for 5 days, or ten instillations in all. 12 hours after the last instillation, each animal received 1 ce. of the virus suspension into each nostril on 3 successive days. One animal died of dysentery. Of the 6 remaining 2 Kramer, S. D., Schaeffer, M., and Park, W. H., J. Immunol., 1934, 27, 199. animals, 2 succumbed, 4 resisted infection. Of the 4 surviving animals, one received a second series of three nasal instillations of virus 15 days after the first intranasal test. This animal died of tuberculosis 25 days later. A second intranasal test was done on one animal 75 days after the first nasal test, the remaining 2 animals were tested 100 days after the first intranasal test. All 3 animals survived. Neutralization tests performed on three serums obtained 18 days and one obtained 57 days after the first exposure to the virus, showed that 2 animals had developed neutralizing substance; two serums failed to neutralize. An intracerebral test performed on 2 animals 111 days and on one animal 86 days after the first intranasal test resulted in the experimental disease in all 3 animals; one animal developing a mild attack from which it recovered. Of the 14 controls used, all but one succumbed within the usual incubation period of the virus; the single survivor being one of the 4 used as intranasal controls.
Experiment 2.--Each of 6 animals was treated with pitnitrin S and adrephine, for 5 days, in the same manner as the animals in Experiment 1. 24 hours after the last treatment, 2 of this group received the first of three daily doses of virus intranasally; 1 cc. into each nostril. 2 additional animals received the first of three daily doses 48 hours after the last treatment, and the last 2 animals received virus 96 hours after the last treatment. The 2 animals which were infected 24 hours after the last treatment resisted infection. Of the remainder, 2 succumbed to the disease, a third, No. 9-3, died of a rapidly progressing anemia, and the other died an accidental death. Neutralization tests were done on the serums of the 2 survivors, obtained 21 days after the last inoculation with virus; both serums neutralized. A second intranasal test was performed 43 days after the first series of intranasal instillations; both animals survived. Intracerebral tests were performed 56 days after the first intranasal test; one animal survived and one succumbed after a prolonged incubation period (27 days). All of the 11 controls used in this experiment succumbed to the disease.
Protective Action of Pituitrin S and Adrephine (7 Days of Treatment)
Experiment 3.--Six animals received two daily instillations of pituitrin S and adrephine 12 hours apart for 7 days. 24 hours after the last treatment (Sth day), 2 of these animals received the first of three daily intranasal doses of virus; a second pair of animals received the first intranasal dose of virus 48 hours after the last treatment; and the last 2, 96 hours after the last treatment. Both animals infected 96 hours after the last treatment succumbed. One of the 2 animals infected 48 hours after the treatment succumbed and one survived. Both animals infected 24 hours after the last treatment survived. Neutralization tests were done on the serums of the 3 surviving animals, obtained 24 days after the third instillation of virus; two neutralized and one failed to do so. The animals were tested intranasally a second time 26 and 27 days after the first intranasal test; all survived. Intracerebral tests performed 40 to 41 days after the first intranasal test, resulted in the experimental disease in 2 of the 3 animals. All 10 controls succumbed.
Of the 19 animals included in these three experiments, 9 survived the intranasal test and 2 died from causes other than poliomyelitis. 6 of the group developed neutralizing substance in the blood serum, 2 of these 6 withstanding intracerebral inoculation. One animal succumbed to the intracerebral test after a prolonged incubation period (27 days), and a second succumbed to a mild attack from which it recovered. Of the 9 animals, all but one had received virus 12 to 24 hours after completion of the treatment with pituitrin S and adrephine; the ninth animal received virus 48 hours after the last treatment. The animals which had received virus after 96 hours, all succumbed. 34 of the 35 controls used in these 4 experiments developed the experimental disease.
Action of Pituitrin S and Adrephine in Combination with Virus
Experiment 4.--2 animals received daily instillations of both pituitrin S and adrephine, as well as virus. The pituitrin S and adrephine were instilled at 11 a.m. and the virus at 5 p.m. One of these animals succumbed to the disease in 11 days; the control having come down in 7 days. Daily treatment with pituitrin S and adrephine and instillations of virus was continued on the surviving animal for 28 days when it was discontinued, and on the 29th, 30th, and 31st days the animal received instillations of virus alone. The animal survived. Serum, obtained 29 days after the beginning of the experiment, failed to neutralize the virus. 9 days after the intranasal test, the animal was inoculated intracerebrally with an infective dose of a 5 per cent suspension of virus in 1 cc. of saline and survived. All 6 controls succumbed to the experimental disease.
Experiment 5.--4 animals received daily two treatments of pituitrin S and adrephine (at 9 a.m. and 5 p.m. respectively). At 1 p.m., or 4 hours after the first treatment, the animals received 1 cc. of a 5 per cent suspension of virus into each nostril. 2 of the group succumbed to the experimental disease in 9 days. The remaining animals survived 20 days of treatment and nasal instillations of virus, at which time the treatment and virus instillations were discontinued. They were tested by intranasal instillations of virus on the 21st, 22nd, and 23rd days; both survived. Neutralization tests were performed on the serums of these animals, obtained 20 days after the beginning of the experiment; both neutralized. Intracerebral tests were performed 9 days after the last intranasal test; both animals survived. All 5 controls employed in this experiment succumbed.
Experiment 6.---4 additional animals received the same daily treatments and exposures to virus as in Experiment 5. One animal succumbed in 9 days after the last inoculation of virus; 3 survived 22 days of treatment and exposure to virus. Neutralization tests were done on the serums obtained 22 days from the beginning of the experiment; one serum neutralized, one showed partial neutralization, and one failed to neutralize. Intracerebral tests were done 23 days from the time the experiment was started; one animal succumbed to the experimental disease and 2 survived. The 4 controls employed in this experiment succumbed.
The survival of 5 animals in the above three experiments suggested the development not only of resistance to intranasal infection, but apparently of an active immunity, as indicated by their resistance to intracerebral inoculation and the appearance of neutralizing substance in the blood serums. These experiments were therefore repeated.
Experiments 7 and &--One group of 4 animals (Experiment 7), received daily for 31 days a single instillation of pituitrin S and adrephine at 11 a.m., followed by virus at 5 p.m. A Second group of 4 animals (Experiment 8), received daily for 31 days two treatments with pituitrin S and adrephine at 9 a.m. and 5 p.m. respectively, combined with virus instilled at 1 p.m. Only one of the animals which had received a single treatment of pituitrin S and adrephine survived. That single animal, however, developed neutralizing substance in its serum 31 days after the beginning of the treatment, survived an intranasal test, and resisted the intracerebral test done 54 days from the beginning of the experiment. 3 of the 4 animals which had received two treatments and one instillation of virus survived; all 3 withstood an intranasal test and 2 resisted an intraeerebral inoculation. Only one of the 3 animals developed demonstrable neutralizing substance, and that animal was one of the 2 that resisted the intracerebral test. All 22 controls in these two experiments succumbed.
Of the 18 animals used in these five experiments, which had received treatment with pituitrin S and adrephine in combination with virus instillations, 10 survived. 2 of these 10 survivors belonged to the group which were treated with pituitrin S and adrephine once a day, the remaining 8 twice a day. 5 of the 10 survivors developed neutralizing substance in their blood. 7 of the animals were tested intranasally and all survived. 8 of the group survived the intracerebral test. All of the 37 controls used in these five experiments succumbed to the experimental disease.
Action of Pituitrin S and Adrephine Administered in Combination with Virus Preceded by 5 Days Preliminary Treatment
Experiment 9.--4 animals received preliminary treatment with pituitrin S and adrephine once a day for 5 days. From the 6th day on and daily for 26 days they received instillations of pituitrin S and adrephine at 11 a.m., and of virus at 5 p.m. 3 animals succumbed in 8, 11, and 18 days respectively. The one animal which survived this procedure developed neutralizing substance 26 days after beginning treatment and virus instillations. It resisted an intranasal test, and also intracerebral inoculation 54 days from the beginning of the experiment. 14 controls were used, all of which succumbed to the experimental disease. Experiment 10.--4 animals received preliminary treatments with pituitrin S and adrephine, at 9 a.m. and 5 p.m. daily for 5 successive days. On the 6th day, instillations of virus (administered at 1 p.m.) were combined with the treatment and continued for 26 days. Of the 4 animals, one was found dead 17 days after the beginning of the experiment, but as indicated by histologic examination, not of poliomyelitis. The 3 remaining animals survived. All 3 developed neutralizing substance in their serums by the 26th day after the onset of the combined procedure, resisted an intranasal test, and also an intracerebral test performed 54 days from the beginning of the experiment. All 14 controls used in this experiment succumbed.
In the following two experiments a spray was employed in introducing the pituitrin S and adrephine, instead of the pipette as in the previous experiments.
Experiment 11.----6 animals received a single application a day of pituitrin S and adrephine by the spray method on 5 successive days, and beginning with the 6th day and daily for 24 days the applications of pituitrin S and adrephine were administered at 11 o'clock in the morning and virus dropped into the nostrils at 5 o'clock in the afternoon. Of the 6 animals, 5 succumbed, in from 9 to 23 days. The single survivor developed neutralizing substance 24 days after the onset of the combined treatment and virus instillations, resisted an intranasal test, and survived an intracerebral test performed 46 days from the onset of the experiment. The 7 controls used in this experiment succumbed.
Experiment 12.--8 animals received daily two treatments with pituitrin S and adrephine (at 9 a.m. and 5 p.m. respectively), instilled by spray on 5 successive days. Treatment twice daily with pituitrin S and adrephine in combination with a single daffy instillation of virus at 1 p.m. was continued for 26 days. 7 of the 8 animals survived this procedure. 5 of the 7 animals developed neutralizing substance 26 days from the onset of the combined treatment and virus administration. 6 of the group resisted an intranasal test and also the intracerebral test performed 47 days from the beginning of the experiment. All of the 11 controls succumbed to the experimental disease.
Twenty-two animals were included in these four experiments. All received preliminary treatment with pituitrin S and adrephine for 5 successive days and this was followed by combined treatment and virus administration. 12 survived. Of this number 2 belonged to the group which had received treatment with pituitrin S and adrephine once a day; the remaining 10 animals had received two treatments a day. 11 of the 12 animals survived intranasal and intracerebral tests, l0 developed neutralizing substance in their blood.
Protective Action of A drephine Experiment 13.--4 animals received 2 treatments with adrephine (at 9 a.m. and 5 p.m.), and virus at 1 p.m. 2 survived 37 combined daily treatments with adrephine and instillations of virus. Both of these animals developed neutralizing substance 37 days after the onset of the experiment; they both resisted an intranasal test and survived the intracerebral test, which was performed 59 days from the beginning of the experiment. All of the 9 controls succumbed within the incubation period of the disease.
Experiment 14.--3 animals received preliminary treatments with adrephine twice a day for 5 days. On the 6th day, 12 hours after the last treatment, the animals received the first of the 3 daily instillations for the intranasal test. One of the 3 animals was found dead 2 days after the virus was first administered (dysentery). The 2 remaining animals resisted the intranasal test; the blood serum, obtained 21 days from the day the intranasal test was started, neutralized the virus. Both animals resisted a second intranasal test done 21 days after the first, and both resisted intracerebral inoculation 33 days after the first intranasal test. AM of the 7 controls succumbed to the experimental disease.
Protective Action of Pituitrin S Experiment 15.--Three animals were treated twice a day (at 9 a.m. and 5 p.m.), with pituitrin S alone, and given one instillation of virus daily at 1 p.m. All 3 animals succumbed from 18 to 21 days after the beginning of the experiment.
The results of those three experiments seem to indicate that the protective action is largely due to the adrephine, the pituitrin S probably playing a secondary r61e. This is in accord with our original idea, since the pituitrin S was used to prolong the action of the adrephine? Experiment 17.--4 animals received preliminary nasal instillations once a day for 5 days with a solution of 0.5 per cent each of alum sulfate-picric acid, and from the 6th day on the animals received daily instillations of alum sulfate-picric acid at 11 a.m., and instillations of virus at 5 p.m. All 4 animals succumbed 7 to 21 days after the virus was started. The 4 controls succumbed within the incubation period of the virus.
Experiment 18.--4 animals received preliminary treatments with the alum sulfate-picric acid solution for 5 days. This was followed by daily intranasal instillations of virus alone. 3 of the group succumbed to frank attacks of the experimental disease, and the fourth was found dead on the 14th day, without having given any clinical signs or histologic evidence of poliomyelitis. The 4 controls succumbed.
The results of these experiments seem to indicate that solutions containing mixtures of alum sulfate and picric acid convey only partial protection to intranasal infection. There is no indication, furthermore, that prolonged exposure to virus alone, or in combination with solutions of alum sulfate and picric acid results in an active immunity.
Solutions of Zinc Sulfate.--In the following/our experiments, 0.5 per cent solution of zinc sulfate in saline 5 was employed in place of pituitrin S and adrephine.
Experiment 19.--3 animals received daily for 5 days single instillations of zinc sulfate, and on the 6th day the first of the three daily instillations of virus. All 3 animals survived this first intranasal test; 2 animals succumbed to a second intranasal test 22 days later. The animal which survived failed to resist the intracerebral test performed 23 days after the second intranasal test. The serum of this animal did not neutralize the virus. The 6 control animals succumbed to the experimental disease.
Experiment 20.--4 animals received daily for 5 days single preliminary treatments with a solution of zinc sulfate and then single daily treatments with zinc 5 Schultz, E. W., and Gebhardt, L. P., Proc. Soc. Exp. Biol. and Med., 1937, .*5, 524.
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,537 sulfate at 11 a.m., and instillations of virus at 5 p.m. 3 of the animals succumbed to the experimental disease; one survived 26 days of combined procedure of treatment and virus administration. The serum of the surviving animal, obtained 27 days after the virus was first given, neutralized but death by tuberculosis occurred a few days after the intracerebral test was done. 6 of the 7 controls succumbed; the one which failed to come down was one of the 4 animals used as intranasal controls.
.Experiment 21.--2 additional animals treated in the same manner as the animals in Experiment 18, survived 30 days of treatment and exposure to virus. The serums of both animals failed to neutralize the virus and they succumbed to the intracerebral test performed 30 days from the beginning of the combined treatment and administration of virus. The 3 normal controls succumbed.
Experiment 22.--4 animals received preliminary treatments of single daily
instillations with the zinc sulfate solution for 5 days; this was followed by daily instillations of virus alone. 3 of the 4 animals survived 26 days; one succumbed in 6 days. The serum of 2 of the survivors failed to neutralize the virus; while that of the third animal neutralized on the first test and failed when repeated. All 3 animals succumbed to the intracerebral test given 33 days after the beginning of the experiment. The single animal, whose serum neutralized the virus on the first neutralization test, succumbed to the intracerebral test with an incubation period of 18 days. 6 of the 7 controls succumbed; the single survivor was one of the 4 animals used as intranasal controls.
It appears from these experiments that zinc sulfate offers effective protection against infection by the intranasal route for a period of about a month. However, these animals fail to give any definite evidence of the development of an active immunity, following prolonged daily exposure to the virus alone or in combination with zinc sulfate.
Experiment to Determine Presence or A bsence of Delayed Protection of
Pituitrin S and Adrephine Experiment 23.--Each of 6 animals received two daily instillations 12 hours apart of pituitrin S and aclrephine for 7 consecutive days. 2 weeks later 2 of these animals received the first of three daily intranasal instillations of 1 cc. of a 5 per cent suspension of virus into each nostril; the second 2 animals were similarly tested by intranasal instillations of virus 4 weeks after treatment with pituitrin S and adrephine; and the last 2 animals were tested 6 weeks after treatment. No delayed protective action was evident. 5 animals succumbed to the intranasal test, and the sixth died of intercurrent infection shortly after the intranasal test was started. The 6 controls developed the experimental disease.
Protective Action of Subcutaneous Inoculations of Pituitrin S and Adrephine
In the following experiment the protective action against intranasal infection by pituitrin S and adrephine, when these substances are administered subcutaneously, was tested.
Experiment 24.--3 animals were inoculated subcutaneously with 1 co. pituitrin S and 5 minutes later with 1 cc. adrephine. This procedure was repeated twice daily, at an interval of 8 hours (9 a.m. and 5 p.m.) for 5 consecutive days. On the 6th day these 3 animals and 2 controls all received the first of three instillations of the intranasal test. All of the animals succumbed, suggesting that subcutaneous injections of pituitrin S and adrephine afford no protection to intranasal infection.
Effect of Pituitrin S and Adrephine on Some of the Formed Blood Elements
In the following two experiments an attempt was made to determine if there were alterations in the type or total number of some of the formed blood elements following the administration of pituitrin S and adrephine by the intranasal and subcutaneous routes. The blood elements studied were total red and white cell counts and differential counts.
Experiment 25.--A group of 6 normal animals was selected and blood studies were done daily for 4 days to establish the degree of variation in these dements. On the next day and on the 4 succeeding (5 days in all), the animals received intranasal instillations of pituitrin S and adrephine twice daily, 12 hours apart (9 a.m. and 9 p.m.), and blood counts were done at 1 p.m. On the 6th day after beginning this treatment, the pituitrin S and adrephine were discontinued and all the animals received daily for 3 successive days single instillations of 5 per cent suspensions of virus (1 cc. into each nostril). The daily blood counts were continued for a period of about 2 weeks after the three doses of virus had been administered, or until the animals succumbed.
Experiment 26.--2 additional animals received daily for 7 days subcutaneous inoculations of increasing doses of adrephine. The initial dose of adrephine was 0.3 cc., and this was gradually increased so that the final dose was 1 cc. Blood counts were taken on these animals daily for the 7 days, approximately 4 hours after subcutaneous inoculation of the adrephine.
The total red blood ceils of the 6 animals in Experiment 25, with one exception, remained relatively uniform throughout the study, this single animal dying of a severe progressive anemia. The white blood cells, however, showed frequent and marked variations, varying in one instance (monkey 9-1) from a minimum of 8,000 to a maximum of 30,000 per c.mm. without detectable cause. These variations occurred in haphazard fashion throughout all of the four phases of the experiment: the 4 days preliminary observation, the 5 days of treatment with pituitrin S and adrephine, the 3 days during which the virus was administered, and the final 12 day period of observation. This was true also of the differential counts particularly involving the adult segmented neutrophilic leucocytes, these frequently varying as much as 100 per cent without any appreciable associated changes in the total white counts. Eosinophiles appeared with considerable irregularity. During the 4 day preliminary period of observation, they were found but 3 times in the total of 24 counts. Two of the counts showed 1 per cent, the third 2 per cent. During the period of treatment with pituitrin S and adrephine, the eosinophiles were found 15 times out of a total of 30 counts, the percentage varying from 1 per cent to 4 per cent. During the 3 days when virus alone was administered, they were found 8 times in the 18 counts done. In the 34 blood counts done during the last 12 days of the study, eosinophiles were observed 13 times, varying from 1 per cent to 5 per cent of the total white count.
There appeared to be, therefore, a tendency for eosinophiles to appear more frequently when the pitnitrin S and adrephine were administered, and to drop off slowly when these substances were discontinued. The figures, however, are small and no definite conclusion can be drawn.
The presence of eosinophiles appears to have some relationship to the occurrence of intestinal parasites in this experimental animal. Such infections are common in the monkey. Ova of the parasites are frequently found in the stool, and at autopsy small cysts containing round worms are encountered along the root of the mesentery. The animals used in Experiment 25 of the blood studies given above, were fresh stock recently imported from India. Blood counts done for 2 successive days on 6 animals which had been in the laboratory for a period of many months tended to show eosinophiles in their blood streams more frequently; of the 13 blood counts done on these 6 animals, from 1 per cent to 3 per cent eosinophiles were found 8 times, suggesting that old laboratory monkeys tend to show eosinophiles more frequently, possibly as a result of their intestinal infestations.
In the 2 animals which had received the adrephine by subcutaneous inoculation (Experiment 26), eosinophiles were found 7 times in the 14 counts done, the percentage varying from 1 per cent to 3 per cent. There appeared to be no correlation between the appearance of eosinophiles and the increasing doses of adrephine. The red blood cells in these animals remained fairly uniform, whereas the white cells tended to show similar, though less marked variations than the other animals studied.
Actions of Pituitrin S and Adrephine and Their Component Substances on the Virus in Vitro
The following experiments were devised to determine the action of the components of pituitrin S and adrephine on the virus.
The commercial preparation known as adrephine is an acid (hydrochloric) solution containing adrenalin (1:10,000), and 2 per cent ephedrine sulfate with a pH of 4.04.2. The pH of the pituitrin S is about 3.4, due to the presence of acetic acid. Both solutions contain 0.5 per cent chloretone as a preservative. The following solutions were prepared: (a) hydrochloric acid, pH 4; (b) acetic acid, pH 3.4; (c) adrephine diluted with an equal amount of saline; (d) pituitrin S diluted with an equal amount of saline; (e) 0.5 per cent solution of chloretone.
Experiment g7.--To 1 cc. of each of these solutions, 0.1 cc. of normal monkey serum was added and the mixtures kept at room temperature for 1/6 hour. Two infective doses of virus in 1 cc. of saline were then added to each test tube, thoroughly shaken, placed in the incubator for 2 hours, and kept in the ice chest overnight. The following morning 1.2 cc. from each test tube was inoculated intracerebrally into test animals. 2 controls were given virus and saline. The test animal inoculated with the adrephine-virus mixture was the only one which survived, all the others, as well as both controls, developing the disease.
Experiment 28.--A mixture was prepared of equal parts of adrephine and a 10 per cent virus suspension (Armstrong strain). A portion of this mixture was permitted to stand at room temperature for 30 minutes, following which it was introduced into the nostrils of 2 normal monkeys (1 cc. into each nostril). The 2 control animals received 1 cc. of a 5 per cent suspension of virus into each nostril. The balance of the mixture of virus and adrephine was incubated for 2 hours at 37°C. and kept overnight in the ice chest. On the following morning 2 normal animals received intranasal instillations of this mixture (1 cc. into each nostril). 2 control animals received instillations of a 5 per cent suspension of virus which had been incubated for 2 hours and kept in the ice chest overnight. This procedure was repeated daffy for 3 successive days.
The 2 animals which had received instillations of adrephine and virus kept at room temperature for 30 minutes, as well as the 2 controls which had received instillations of 5 per cent virus suspensions, succumbed to the disease within the incubation period of the virus. The 2 animals which had received instillations of the adrephine-virus mixture which had been incubated for 2 hours and kept overnight in an ice chest failed to come down. The 2 corresponding controls succumbed to the experimental disease.
It would therefore appear that under the experimental conditions, adrephine possesses some viricidal properties, although this is evident only after incubation at 37°C. and prolonged contact with the virus.
Histologic Studies of the Mucous Membranes of Animals Treated with Pituitrin S and Adrephine
Preliminary studies of the nasal mucous membranes of 12 animals treated with pituitrin S and adrephine show a mild active inflammatory reaction 12 to 96 hours after treatment. There was hyperemia of the corium with local leucocytosis, margination, and exudation into the interstitial tissue. This appeared to be a fairly constant feature in all of the sections studied. Various types of leucocytes were found in varying numbers, and in several of the animals sacrificed 12 and 24 hours after the last treatment, eosinophiles were prominent both in the corium and migrating through the epithelial layer of the mucous membrane. There was no desquamation or necrosis and edema was not conspicuous. There was no fibrin lining the mucous layer. This preliminary histologic investigation has served to indicate that no severe inflammatory or degenerative effects are to be expected from instillations of these materials. A more detailed study of the changes in the mucous membrane is being made.
R~sum~ of the Findings
The results of the preliminary experiments indicated that protection against intranasal infection was obtained in almost two-thirds of the animals which had received instillations of pituitrin S and adrephine twice a day for 5 days, when the intranasal test was begun 12 to 24 hours after the last administration of pituitrin S and adrephine. 8 of the 11 animals which had received such treatment resisted two intranasal tests. Only one of the 3 animals which had received virus 48 hours after the last treatment of pituitrin S and adrephine survived. Of the 7 animals in these experiments which succumbed to the first intranasal test, 5 had been tested intranasally 48 to 96 hours after the treatment, and 2, 12 hours after treatment.
There was some indication in these preliminary experiments that the first intranasal test gave rise to an active immunity in some instances, since of the 9 animals which had resisted the first intranasal test, 6 had developed neutralizing substance in their serums from 18 to 21 days after the virus had been administered; all of these 9 survivors resisted a second intranasal test, performed from 26 to 100 days after the first intranasal test, and 2 animals resisted the intracerebral test. A third animal came down with a prolonged incubation period of 27 days, and a fourth animal came down with a mild attack of the disease from which it recovered. Eighteen animals received continued daily treatments with pituitrin S and adrephine in combination with daily instillations of virus. 6 of these 18 animals received one treatment a day, and 12 animals received two daily treatments. Of the 6 which had received a single treatment, 2 survived the intranasal test, one developed neutralizing substance in its serum, and both resisted an intracerebral test. Of the 12 animals which had received treatment twice a day, 8 survived; 4 of these developed neutralizing substance in their blood, and one serum partially neutralized the virus. 6 of the 8 resisted the intracerebral test.
Twenty-two additional animals received combined treatment and virus instillations, subsequent to 5 days preliminary treatment with pituitrin S and adrephine before administration of the virus was started. 10 of these 22 animals received one treatment with pituitrin S and adrephine a day, and 12 animals received two such treatments a day. Of the 10 animals which had received a single treatment in combination with virus, 2 survived the procedures. Both of these animals resisted intranasal infection; both developed neutralizing substance in their serums, and resisted the intracerebral test. Of the 12 animals which had received two treatments a day in combination with virus, 10 survived; 9 of the animals resisted the intranasal test, 8 developed neutralizing substance in their serums, and 9 resisted the intracerebral test.
In the two small experiments in which adrephine alone was used, the results were essentially the same as when pituitrin S and adrephine were employed. The 2 animals a which had received 5 days of treat-6 A third animal used in this experiment died from an intercurrent infection shortly after the experiment was started. ment with adrephine twice a day and intranasal test begun 12 hours after the last treatment, survived; both animals developed neutralizing substance in their blood serum, resisted a second intranasal test, and both resisted an intracerebral test. Of the 4 animals which had received daily administration of adrephine alone in combination with virus, 2 survived the prolonged exposure to adrephine and virus. Both animals survived intranasal tests, developed neutralizing substance in their serums and survived the intracerebral test. There was little or no indication that pituitrin S when used alone afforded protection, since all 3 animals thus treated succumbed, though 2 of them lived for 21 days after the beginning of the experiment, and the third for 18 days.
Pituitrin S and adrephine adm~uistered subcutaneously afforded no protection against intranasal infection, nor did these substances appear to exert a delayed reaction when administered by the intranasal route since all of the animals tested intranasally, 2, 4, and 6 weeks after the 7 days treatment, succumbed.
There was some suggestion that the intranasal and subcutaneous administration of pituitrin S and adrephine resulted in a slight eosinophilic response in the blood stream, but this appeared to be transient and was not marked. A somewhat more pronounced local eosinophilic response, however, was noted in the mucous membranes of the animals which had received intranasal instillations of pituitrin S and adrephine. This was noted in animals sacrificed 12 and 24 hours after treatment. The eosinophiles were part of the mild general inflammatory reaction of the mucous membranes in all of the treated animals.
There was some indication that adrephine possessed some viricidal action, but this was evident only after incubation for 2 hours at 37°C., and prolonged contact with the virus.
In the seven comparable experiments in which solutions of alum sulfate-picric acid and zinc sulfate were employed in place of pituitrin S and adrephine, there was no indication of any alteration in the underlying susceptibility of the animals, as indicated by their failure to develop neutralizing substance in their blood and their inability to resist the intracerebral test. Most of the animals treated with zinc sulfate were protected against intranasal infection for about a month.
Animals treated with alum sulfate-picric acid showed a less constant protection against intranasal infection, than the zinc sulfate-treated animals. The survivors of both groups of animals succumbed to the intracerebral test.
SITM~tARY
The experiments reported above indicate that the intranasal instillations of pituitrin S and adrephine, alter susceptibility in the rhesus monkey. One-half to two-thirds of the treated animals resisted intranasal infection, and, moreover, most of the resistant animals which had received combined treatment and virus developed active immunity, as indicated by the presence of neutralizing substance in their serums and by their ability to resist intracerebral infection. We have, it appears, not alone modified in some fashion the usual reaction of this animal to intranasal infection, but we have also successfully vaccinated these animals by the nasal route, so that the response in animals more nearly approaches what we believe to be the response in human beings.
We have no knowledge of the mechanism by means of which pituitrin S and adrephine produce this apparent alteration in susceptibility, but since the outcome of continued exposure to virus in most of the animals treated with these substances results in immunity, we believe that this offers a more hopeful approach toward the control of the disease.
